Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:cronsb01

Total Results:

378


Netrin-1 and Its Receptors Unc5b and DCC May be Useful Targets for Preventing Multiple Myeloma Bone Lesions [Meeting Abstract]

Mediero, Arynzazu; Mazumder, Amitabha; Cronstein, Bruce
ISI:000368019005293
ISSN: 1528-0020
CID: 2019722

Adenosine A2A Receptor, but Not A2B Receptor, Deletion Leads to Development of Osteoarthritis (OA) in Mice and Administration of a Liposomal Suspension of Adenosine Prevents/Treats Osteoarthritis in Rats [Meeting Abstract]

Corciulo, Carmen; Lendhey, Matin; Ramme, Austin; Wilder, Tuere; Kennedy, Oran; Cronstein, Bruce
ISI:000370860203416
ISSN: 2326-5205
CID: 2029362

Designing and Implementing INTREPID, an Intensive Program in Translational Research Methodologies for New Investigators

Plottel, Claudia S; Aphinyanaphongs, Yindalon; Shao, Yongzhao; Micoli, Keith J; Fang, Yixin; Goldberg, Judith D; Galeano, Claudia R; Stangel, Jessica H; Chavis-Keeling, Deborah; Hochman, Judith S; Cronstein, Bruce N; Pillinger, Michael H
Senior housestaff and junior faculty are often expected to perform clinical research, yet may not always have the requisite knowledge and skills to do so successfully. Formal degree programs provide such knowledge, but require a significant commitment of time and money. Short-term training programs (days to weeks) provide alternative ways to accrue essential information and acquire fundamental methodological skills. Unfortunately, published information about short-term programs is sparse. To encourage discussion and exchange of ideas regarding such programs, we here share our experience developing and implementing INtensive Training in Research Statistics, Ethics, and Protocol Informatics and Design (INTREPID), a 24-day immersion training program in clinical research methodologies. Designing, planning, and offering INTREPID was feasible, and required significant faculty commitment, support personnel and infrastructure, as well as committed trainees. Clin Trans Sci 2014; Volume #: 1-7.
PMCID:4267993
PMID: 25066862
ISSN: 1752-8062
CID: 1089772

Loss or blockade of adenosine A2B receptor prevents fatty liver by down-regulating microRNA expression [Meeting Abstract]

Liu, Hailing; Cronstein, Bruce; Wilder, Tuere
ISI:000348578700456
ISSN: 1573-9546
CID: 1477392

Adenosine A(2A) receptor (A2AR) diminishes wear particle (UHMWPE)-mediated osteolysis, increases bone formation and regulates expression of axonal guidance proteins (AGP) by macrophages, osteoclasts (OC) and osteoblasts (OB) [Meeting Abstract]

Mediero, Aranzazu; Perez-Aso, Miguel; Wilder, Tuere; Cronstein, Bruce
ISI:000348578700366
ISSN: 1573-9546
CID: 1477382

Adenosine receptors and tissue fibrosis [Meeting Abstract]

Cronstein, Bruce N; Perez Aso, Miguel; Feig, Jessica
ISI:000348578700055
ISSN: 1573-9546
CID: 1477342

Adenosine receptors stimulate bone regeneration by targeting osteoclasts [Meeting Abstract]

Mediero, Aranzazu; Wilder, Tuere; Cronstein, Bruce
ISI:000348578700364
ISSN: 1573-9546
CID: 1477362

Stimulation of the adenosine A(2A) receptor (A2AR) regulates the expression of Netrin1 and their receptors (Unc5b, DCC) and inhibits osteoclast differentiation and wear particle-induced (UHMWPE) inflammatory osteolysis [Meeting Abstract]

Mediero, Aranzazu; Ramkhelawon, Bhama; Perez-Aso, Miguel; Moore, Kathryn; Cronstein, Bruce
ISI:000348578700365
ISSN: 1573-9546
CID: 1477372

Adenosine A(2A) receptor as a potential new therapeutic target for the prevention/treatment of osteoarthritis [Meeting Abstract]

Corciulo, Carmen; Mediero, Aranzazu; Wilder, Tuere; Cronstein, Bruce
ISI:000348578700361
ISSN: 1573-9546
CID: 1477352

Activation of EPAC1/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements

Mediero, Aranzazu; Perez-Aso, Miguel; Cronstein, Bruce N
Bisphosphonates inhibit osteoclast differentiation/function via inhibition of Rap1A isoprenylation. As Rap1 is the effector of exchange protein directly activated by cAMP (EPAC) proteins, we determined the role of EPAC in osteoclast differentiation. We examined osteoclast differentiation as the number of primary murine/human bone-marrow precursors that differentiated into multinucleated TRAP-positive cells in the presence of EPAC-selective stimulus (8-pCTP-2'-O-Me-cAMP, 100 muM; 8-pCTP-2'-O-Me-cAMP-AM, 1 muM) or inhibitor brefeldin A (BFA), ESI-05, and ESI-09 (10 muM each). Rap1 activity was assessed, and signaling events, as well as differentiation in EPAC1/2-knockdown RAW264.7 cells, were studied. Direct EPAC1/2 stimulation significantly increased osteoclast differentiation, whereas EPAC1/2 inhibition diminished differentiation (113+/-6%, P<0.05, and 42+/-10%, P<0.001, of basal, respectively). Rap1 activation was maximal 15 min after RANKL stimulation (147+/-9% of basal, P<0.001), whereas silencing of EPAC1/2 diminished activated Rap1 (43+/-13 and 20+/-15% of control, P<0.001) and NFkB nuclear translocation. TRAP-staining revealed no osteoclast differentiation in EPAC1/2-KO cells. Cathepsin K, NFATc1, and osteopontin mRNA expression decreased in EPAC1/2-KO cells when compared to control. RhoA, cdc42, Rac1, and FAK were activated in an EPAC1/2-dependent manner, and there was diminished cytoskeletal assembly in EPAC1/2-KO cells. In summary, EPAC1 and EPAC2 are critical signaling intermediates in osteoclast differentiation that permit RANKL-stimulated NFkB nuclear translocation and actin rearrangements. Targeting this signaling intermediate may diminish bone destruction in inflammatory arthritis.-Mediero, A., Perez-Aso, M., Cronstein, B. N. Activation of EPAC1/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements.
PMCID:4200330
PMID: 25122553
ISSN: 0892-6638
CID: 1341742